Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010:2010:434562.
doi: 10.1155/2010/434562. Epub 2010 Jan 21.

The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors

Fernando Cordido  1 , Jesús Garcia-Buela, Susana Sangiao-Alvarellos, Teresa Martinez, Ovidio Vidal
Affiliations

The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors

Fernando Cordido et al. Mediators Inflamm. 2010.

Abstract

The aim of the present study was to evaluate the relationship between GHRH-induced GH secretion in obese premenopausal women and cardiovascular risk markers or insulin resistance. Premenopausal obese women, aged 35-52 years, were studied. GH secretion, IGF-I, serum cardiovascular risk markers, insulin, leptin, mid-waist and hip circumference, total body fat, and truncal fat were measured. Subjects were classified as meeting the criteria for GH deficiency (GHD) when peak GH after stimulation with GHRH was <or=3 microg/L. Mean total and LDL cholesterol, fasting insulin, and HOMA-IR were all higher, in subjects who would have been classified as GH-deficient compared with GH-sufficient. Peak GH secretion after stimulation was inversely associated with fasting insulin (R = -0.650, P = .012), HOMA-IR (R = -0.846, P = .001), total cholesterol (R = -0.532, P = .034), and LDL cholesterol (R = -0.692, P = .006) and positively associated with HDL cholesterol (R = 0.561, P = .037). These data strongly suggest a role for insulin resistance in the decreased GH secretion of obesity and that the blunted GH secretion of central obesity could be the pituitary expression of the metabolic syndrome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean ± SEM GH secretion in obese premenopausal women after stimulation with GHRH.
Figure 2
Figure 2
Mean ± SEM peak GH secretion in obese premenopausal women after stimulation with GHRH, divided in two groups, above or below BMI median (P = .005).
Figure 3
Figure 3
Mean ± SEM total and LDL cholesterol in GH-Deficient and GH-Sufficient Obese patients (P = .044).
Figure 4
Figure 4
Mean ± SEM hepatic serum aminotransferases: GOT (P = .012), GPT (P = .022), and GGT (P = .007) in GH-Deficient and GH-Sufficient Obese patients.
Figure 5
Figure 5
Mean ± SEM fasting insulin (P = .005) and HOMA-IR (P = .018) in GH-Deficient and GH-Sufficient Obese patients.
See this image and copyright information in PMC

References

    1. de Boer H, Blok G-J, Van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews. 1995;16(1):63–86. - PubMed
    1. Salomon F, Cuneo RC, Hesp R, Sonksen PH. The effects op treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. The New England Journal of Medicine. 1989;321(26):1797–1803. - PubMed
    1. Jorgensen JOL, Pedersen SA, Thuesen L, et al. Beneficial effects of growth hormone treatment in GH-deficient adults. The Lancet. 1989;1(8649):1221–1225. - PubMed
    1. Bülow B, Hagmar L, Eskilsson J, Erfurth EM. Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. The Journal of Clinical Endocrinology & Metabolism. 2000;85(2):574–584. - PubMed
    1. Rosen T, Bengtsson B-A. Premature mortality due to cardiovascular disease in hypopituitarism. The Lancet. 1990;336(8710):285–288. - PubMed

Publication types